Learn More
Medchemexpress LLC bFGF (119-126) | 152051-61-1 | 99.93% | 993.16 | 10 MG

Supplier: Medchemexpress LLC HYP532110MG
bFGF (119-126) is a ligand of basic fibroblast growth factor (bFGF) that inhibits its interaction with fibroblast growth factor receptor 1 (FGFR1). This suppresses FGFR1 phosphorylation and downstream signaling, leading to cell apoptosis and inhibition of proliferation, migration, angiogenesis, and metastasis. It can enhance cellular uptake when conjugated with a carrier and has shown enhanced tumor inhibitory effects in combination with ultrasound and Doxorubicin, useful in various cancer research.
- Enhances cellular uptake via FGFR-mediated endocytosis when conjugated with a carrier
- Effective FGFR-targeted ligand
- Enhances tumor inhibitory effects when combined with ultrasound and Doxorubicin
- Applicable for research in lung, breast, glioblastoma, and ovarian cancers.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.